Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VIS410 plus oseltamivir versus oseltamivir alone in hospitalized adults with influenza A requiring oxygen support
MOH_2017-10-03_000851Phase 2Completed
- Sponsor
- Visterra
- Start
- Sep 2017
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of VIS410 in Influenza A infection (3 arms), sponsored by Visterra. Started Sep 2017; status: completed.
02
Drugs
VIS410
03
Conditions
Influenza A infection
Beyond the preview
Go deeper on MOH_2017-10-03_000851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2017-10-03_000851.